H Gelderblom Selected Research

H Gelderblom Research Topics

Disease

36	Neoplasms (Cancer) 10/2023 - 04/2000
14	Sarcoma (Soft Tissue Sarcoma) 01/2022 - 01/2011
13	Colorectal Neoplasms (Colorectal Cancer) 07/2021 - 04/2005
12	Breast Neoplasms (Breast Cancer) 06/2023 - 12/2012
9	Neoplasm Metastasis (Metastasis) 10/2020 - 11/2006
4	Thyroid Neoplasms (Thyroid Cancer) 01/2022 - 01/2012
4	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2021 - 07/2012
4	Hypertension (High Blood Pressure) 01/2017 - 10/2007
3	Ewing Sarcoma (Sarcoma, Ewing) 11/2019 - 08/2017
3	Disease Progression 01/2019 - 10/2013
3	Fatigue 01/2018 - 10/2013
3	Osteosarcoma (Osteogenic Sarcoma) 02/2015 - 06/2012
2	Alveolar Soft Part Sarcoma 11/2023 - 01/2018
2	Giant Cell Tumor of Bone 10/2023 - 01/2022
2	Vomiting 01/2018 - 10/2001
2	Nausea 01/2018 - 01/2017
2	Renal Insufficiency (Renal Failure) 01/2018 - 06/2014
2	Rectal Neoplasms (Rectal Cancer) 09/2017 - 04/2015
2	Dihydropyrimidine Dehydrogenase Deficiency 03/2017 - 10/2013
2	Febrile Neutropenia 01/2015 - 07/2008
2	Liver Diseases (Liver Disease) 02/2014 - 07/2008
2	Neutropenia 01/2014 - 10/2001
2	Chondrosarcoma 09/2013 - 06/2012
2	Carcinoma (Carcinomatosis) 07/2012 - 11/2006
2	Hypersensitivity (Allergy) 01/2004 - 09/2001
1	Giant Cell Tumors (Giant Cell Tumor) 10/2023
1	Tics (Tic) 10/2023
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022
1	Melanoma (Melanoma, Malignant) 01/2022
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 07/2021
1	Margins of Excision 11/2019
1	Necrosis 11/2019
1	Giant Cell Tumor of Tendon Sheath 10/2019
1	Chronic Renal Insufficiency 01/2018
1	Myxoid Liposarcoma 08/2017
1	Hemangiosarcoma (Angiosarcoma) 01/2017
1	Syncope (Fainting) 01/2017

Drug/Important Bio-Agent (IBA)

10	Tamoxifen FDA LinkGeneric 06/2023 - 12/2012
8	Imatinib Mesylate (Gleevec)FDA Link 01/2021 - 10/2003
7	Sunitinib (Sutent)FDA Link 01/2018 - 10/2007
7	Capecitabine (Xeloda)FDA Link 09/2017 - 07/2008
7	Cisplatin (Platino)FDA LinkGeneric 01/2016 - 10/2001
7	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2015 - 01/2011
6	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 11/2021 - 03/2013
5	Cetuximab (Erbitux)FDA Link 07/2021 - 11/2006
5	Biomarkers (Surrogate Marker)IBA 10/2020 - 01/2015
5	Oxaliplatin (Eloxatin)FDA LinkGeneric 09/2017 - 04/2005
5	Topotecan (Hycamtin)FDA LinkGeneric 07/2003 - 04/2000
4	Monoclonal AntibodiesIBA 10/2023 - 08/2012
4	Melphalan (Alkeran)FDA LinkGeneric 11/2014 - 09/2007
3	Panitumumab (Vectibix)FDA Link 01/2018 - 08/2012
3	Ifosfamide FDA LinkGeneric 08/2017 - 06/2010
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 08/2017 - 01/2015
3	Fluorouracil (Carac)FDA LinkGeneric 03/2017 - 10/2013
3	AnthracyclinesIBA 01/2017 - 01/2015
3	Docetaxel (Taxotere)FDA Link 01/2016 - 07/2008
3	DNA (Deoxyribonucleic Acid)IBA 01/2015 - 07/2012
3	Irinotecan (Camptosar)FDA LinkGeneric 08/2010 - 07/2008
2	Denosumab FDA Link 10/2023 - 01/2022
2	Epidermal Growth Factor (EGF)IBA 01/2022 - 11/2006
2	Phosphotransferases (Kinase)IBA 11/2020 - 09/2013
2	Tyrosine Kinase InhibitorsIBA 01/2017 - 10/2003
2	Cytochrome P-450 CYP3AIBA 01/2017 - 07/2008
2	Everolimus FDA Link 07/2016 - 01/2015
2	4-hydroxy-N-desmethyltamoxifenIBA 10/2015 - 03/2013
2	ParaffinIBA 01/2015 - 07/2013
2	Mitotane (Lysodren)FDA Link 12/2014 - 06/2008
2	exemestane (Aromasin)FDA Link 07/2013 - 12/2012
2	ErbB Receptors (EGF Receptor)IBA 08/2012 - 11/2006
2	nilotinib FDA Link 07/2012 - 09/2009
1	Immune Checkpoint InhibitorsIBA 11/2023
1	Trastuzumab (Herceptin)FDA Link 01/2022
1	VemurafenibIBA 01/2022
1	cobimetinibIBA 01/2022
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022
1	pertuzumabIBA 01/2022
1	Cytochrome P-450 CYP2C19IBA 11/2021
1	Antineoplastic Agents (Antineoplastics)IBA 01/2021
1	tyrosine receptor (receptor, tyrosine)IBA 11/2020
1	TropomyosinIBA 11/2020
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 10/2020
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 11/2019
1	NivolumabIBA 10/2019
1	CrizotinibIBA 01/2018
1	Transcription Factors (Transcription Factor)IBA 01/2018
1	Bevacizumab (Avastin)FDA Link 09/2017
1	Alkylating AgentsIBA 08/2017
1	SurvivinIBA 08/2017
1	pazopanib FDA Link 01/2017

Therapy/Procedure

19	Drug Therapy (Chemotherapy) 10/2021 - 10/2001
18	Therapeutics 10/2023 - 07/2008
6	Radiotherapy 01/2022 - 06/2012
3	Neoadjuvant Therapy 09/2017 - 06/2012
2	Duration of Therapy 10/2023 - 11/2012
2	Immunotherapy 10/2019 - 07/2012
2	Drug Tapering 07/2016 - 08/2012
2	Adjuvant Chemotherapy 04/2015 - 06/2008
1	Enteral Nutrition (Feeding, Tube) 01/2022
1	Hyperthermic Intraperitoneal Chemotherapy 10/2020
1	Cytoreduction Surgical Procedures 10/2020